Not applicableNot Yet RecruitingNCT06588192What this trial is testingRenal Survival in Patients with Lupus NephritisWho this might be right forLupus Nephritis (LN) Assiut University 97
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292What this trial is testingMSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.Who this might be right forLupus Nephritis (LN)ANCA-Associated Glomerulonephritis Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT07038382What this trial is testingEvaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active GlomerulonephritisWho this might be right forMembranous NephropathyLupus Nephritis (LN) Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Looking for participantsNCT06947460What this trial is testingCD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAHWho this might be right forRefractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension Beijing GoBroad Hospital 45
Not applicableLooking for participantsNCT06682507What this trial is testingHigh Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)Who this might be right forLupus Nephritis (LN) First Affiliated Hospital, Sun Yat-Sen University 5,000
Large-scale testing (Phase 3)UnknownNCT03680261What this trial is testingEnriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. ChemoradiotherapyWho this might be right forGastric Cancer Shanghai Zhongshan Hospital 556
Not applicableLooking for participantsNCT06527872What this trial is testingStudy to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LNWho this might be right forLupus Nephritis GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT03302208What this trial is testingPreoperative Oral Pregabalin Effect on Inhalational Anesthetic Requirements ln Hysterectomy Under General AnesthesiaWho this might be right forHysterectomy Nesrine El-Refai 50
Not applicableStudy completedNCT01329575What this trial is testingPredicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph NodesWho this might be right forNeoplasm of Mediastinal Lymph Nodes Centre hospitalier de l'Université de Montréal (CHUM) 184
Early research (Phase 1)Not Yet RecruitingNCT07123519What this trial is testingA Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune DiseasesWho this might be right forSystemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT07323524What this trial is testingDapagliflozin in Active Lupus NephritisWho this might be right forLupus Nephritis (LN) Brigham and Women's Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07363460What this trial is testingStudy to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LNWho this might be right forLupus Nephritis (LN) Haisco Pharmaceutical Group Co., Ltd. 105
Testing effectiveness (Phase 2)UnknownNCT06113900What this trial is testingAssessment of Safety and Efficacy of SGLT2is Among LN PatientsWho this might be right forLupus Nephritis Ain Shams University 50
Early research (Phase 1)Not Yet RecruitingNCT07236762What this trial is testingAn Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Not applicableUnknownNCT06210464What this trial is testingDisease and Biomarker Profiling of Chinese Lupus NephritisWho this might be right forCharacterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to SocIntegrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease EndotypeValidate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring Nan Shen
Testing effectiveness (Phase 2)Looking for participantsNCT06839976What this trial is testingCD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for LupusWho this might be right forSLESystemic Lupus Erythematosus (SLE)CAR T Cell+4 more Children's Hospital of Philadelphia 24
Testing effectiveness (Phase 2)Looking for participantsNCT07015983What this trial is testingCC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)Who this might be right forLupus Erythematosus, SystemicLupus Nephritis Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89
Post-approval studies (Phase 4)UnknownNCT05495893What this trial is testingMMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LNWho this might be right forMycophenolate MofetilCyclophosphamideLupus Nephritis Second Xiangya Hospital of Central South University 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT05798117What this trial is testingAn Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErythematosusLupus Nephritis Novartis Pharmaceuticals 21
Not applicableStudy completedNCT05404217What this trial is testingClinical Trial to Investigate the Efficacy and Safety of LN-OS-22 on Oxidative Stress and Systemic Inflammation in Overweight and Obese Population.Who this might be right forOxidative Stress Vedic Lifesciences Pvt. Ltd. 64